CELG-RI
Bristol-Myers Squibb Company Ce
Price Chart
Latest Quote
$0.11
+0.00 (+0.00%)
Current Price
| Previous Close | $0.11 |
| Open | $0.11 |
| Day High | $0.11 |
| Day Low | $0.11 |
| Volume | 286 |
Stock Information
| Exchange | NYQ |
📊 Comprehensive Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
Performance History
| YTD | +0.00% |
⭐ Premium Feature
Sign up for free to view detailed scoring breakdown — premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.11 | 286 |
📰 Latest News
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
Zacks • 2026-06-17T13:00:04Z
EHA26: BMS touts positive multiple myeloma data for two pipeline candidates
Clinical Trials Arena • 2026-06-17T10:32:42Z
Edgewise Bounds Between Double-Digit Losses And Gain — What's Going On?
Investor's Business Daily • 2026-06-16T20:06:20Z
3 Dividend Stocks to Hold for the Long Haul
Motley Fool • 2026-06-16T10:35:00Z
Tech Shakeup on the S&P 500
Motley Fool • 2026-06-14T20:53:57Z
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
Motley Fool • 2026-06-13T22:35:00Z
Takeda Designed A Psoriasis Pill Using AI. It Just Walloped Bristol's Sotyktu In A Head-To-Head Test.
Investor's Business Daily • 2026-06-11T20:15:01Z
Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
Motley Fool • 2026-06-11T18:22:00Z
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
BioPharma Dive • 2026-06-11T07:00:00Z
Bristol Myers Squibb Links Brazil Lung Cancer Access To Long Term Story
Simply Wall St. • 2026-06-09T22:17:23Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.